Ken Fisher's TRAX Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 51,549 shares of First Tracks Biotherapeutics, Inc. (TRAX) worth $1.04 M, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ken Fisher has initiated a new position in TRAX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's First Tracks Biotherapeutics (TRAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly First Tracks Biotherapeutics (TRAX) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +51,549 | New Buy | 51,549 | $20.12 |
Ken Fisher's First Tracks Biotherapeutics Investment FAQs
Ken Fisher first purchased First Tracks Biotherapeutics, Inc. (TRAX) in Q2 2026, acquiring 51,549 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held First Tracks Biotherapeutics, Inc. (TRAX) for 1 quarters since Q2 2026.
Ken Fisher's largest addition to First Tracks Biotherapeutics, Inc. (TRAX) was in Q2 2026, adding 51,549 shares worth $1.04 M.
According to the latest 13F filing for Q2 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 51,549 shares of First Tracks Biotherapeutics, Inc. (TRAX), valued at approximately $1.04 M.
As of the Q2 2026 filing, First Tracks Biotherapeutics, Inc. (TRAX) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in First Tracks Biotherapeutics, Inc. (TRAX) was 51,549 shares, as reported at the end of Q2 2026.